RxDoctor Payments DataLook up a doctor →

Larry Salberg, MD

Neurology with Special Qualifications in Child Neurology · Merrillville, INNPI 1073666749

Payments from drug & device makers

$26,597in general payments, 2019–2025

Across 1,412 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$2K
  • AbbVie$2K
  • Jazz Pharmaceuticals Inc.$2K
  • Teva Pharmaceuticals USA, Inc.$2K
  • Novartis$2K
  • Neurocrine Biosciences, Inc.$1K
  • plus $15K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen112$2,390
AbbVie(2 entities)159$1,906
Jazz Pharmaceuticals Inc.86$1,905
Teva Pharmaceuticals USA, Inc.97$1,814
Novartis122$1,576
Neurocrine Biosciences, Inc.37$1,031
AstraZeneca32$768
Avadel CNS Pharmaceuticals, LLC25$682
Lundbeck LLC32$671
Acadia Pharmaceuticals Inc34$633
Acorda Therapeutics, Inc37$609
Axsome Therapeutics, Inc.30$597
Lilly USA, LLC28$591
Bristol Myers Squibb26$585
Inspire Medical Systems, Inc.4$502
Amgen24$483
UCB, Inc.24$479
SK Life Science, Inc.22$468
Johnson & Johnson(2 entities)23$432
Eisai Inc.19$430
Takeda Pharmaceuticals U.S.A., Inc.28$411
EMD Serono, Inc.21$368
Harmony Biosciences LLC24$367
Catalyst Pharmaceuticals, Inc.14$367
Argenx US, Inc.19$363
Pfizer30$356
Neurelis, Inc.12$344
Livanova USA, Inc.9$339
Supernus Pharmaceuticals, Inc.14$314
Corium, LLC13$312
MDD US Operations, LLC17$273
Merz Pharmaceuticals, LLC13$272
Otsuka America Pharmaceutical, Inc.13$268
Genentech USA, Inc.14$256
TG Therapeutics, Inc.15$252
Sunovion Pharmaceuticals Inc.16$244
Adamas Pharmaceuticals, Inc.13$206
Kyowa Kirin, Inc.8$193
Sanofi6$164
Scilex Pharmaceuticals Inc.9$139
Biohaven Pharmaceutical Holding Company Ltd.11$131
Ironshore Pharmaceuticals Inc.7$131
Banner Life Sciences, LLC8$130
Vanda Pharmaceuticals Inc.6$118
Tanabe Pharma America, Inc.7$118
Octapharma USA, Inc.5$111
Upsher-smith Laboratories LLC7$101
Sumitomo Pharma America, Inc.6$94
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$84
Bausch Health US, LLC5$83
Amneal Pharmaceuticals LLC5$75
ANI Pharmaceuticals, Inc.3$68
Avanir Pharmaceuticals, Inc.4$62
Ipsen Biopharmaceuticals, Inc5$62
E.r. Squibb & Sons, L.L.C.3$55
Abbott3$54
Cycle Pharmaceuticals Inc3$53
Almatica Pharma LLC3$52
Otsuka Pharmaceutical Development & Commercialization, Inc.2$51
Itamar Medical Inc1$50

How this compares

$26,597 in reported general payments places this provider in the 80th percentile of 25 neurology with special qualifications in child neurology providers in Indiana.

See all neurology with special qualifications in child neurology providers in Indiana →

Medicare billing

Part B allowed, 2024
$476,501
Medicare patients
632
Services billed
15,732

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology with special qualifications in child neurology in Merrillville

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →